Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
M. Pagadala, V. H. Wu, E. Perez-Guijarro, H. Kim, A. Castro, J. Talwar, T. Sears, C. Gonzalez-Colin, S. Cao, B. Schmiedel, S. Goudarzi, D. Kirani, R. Salem, G. Morris, O. Harismendy, , H. Carter
The paper identifies germline variants associated with the tumor immune microenvironment, linking them to cancer risk and immunotherapy response.
bioRxiv · Apr 14, 2021 · PreprintCancer Biology